通过调节FOXO1的乙化,SIRT6的淘汰减轻了皮肤病中的角质细胞过度增殖和炎症
Chuantao Cheng1, Yuan Wang1, Jia Huo1
1Department of Dermatology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.
International immunopharmacology
|December 29, 2024
概括
在牛皮中,Sirtuin 6 (SIRT6) 的含量升高,导致质细胞的炎症和增殖. 抑制SIRT6促进FOXO1核转位,为牛皮治疗提供了潜在的治疗标.
科学领域:
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 赛尔图因家族 (SIRT) 与各种疾病有关,但SIRT6在牛皮中的特定作用尚未完全理解.
- 牛皮是一种慢性炎症性皮肤疾病,具有复杂的潜在机制.
研究的目的:
- 为了研究SIRT6在牛皮病原发生中的作用.
- 探索SIRT6作为牛皮的潜在治疗点.
主要方法:
- 来自牛皮患者和健康捐赠者的RNA-seq数据的分析.
- 在体外研究中,使用使用M5.5治疗的HaCat细胞进行了实验.
- 在体内研究中,使用伊米基莫德诱导的牛皮的小鼠模型.
- 研究SIRT6倒置/抑制对炎症性细胞因子和细胞增殖的影响.
- 检查对分叉盒O 1 (FOXO1) 乙化和核转位的影响.
主要成果:
- 与非损伤或健康皮肤相比,SIRT6表达在病变性牛皮皮肤中显著上调.
- 在牛皮皮肤,小鼠模型和接受M5治疗的HaCat细胞中,SIRT6和Ki67的调节一直在上升.
- 抑制SIRT6的敲除/抑制抑制了M5诱导的炎症性细胞因子产生 (IL-1β,IL-6,TNF-α) 和角质细胞的增殖.
- 在小鼠模型中,SIRT6抑制降低了表皮厚度和Ki67表达.
- SIRT6操纵影响了FOXO1乙化和核转位,影响了角质细胞的行为.
结论:
- SIRT6在促进角质细胞过度增殖和牛皮炎炎症方面发挥着至关重要的作用.
- 抑制SIRT6通过增加其乙化来增强FOXO1核转位,从而抑制M5诱导的效应.
- 抑制SIRT6是牛皮的有希望的治疗策略.
相关概念视频
Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
T Cell Types and Functions
947
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
947
Renewal of Skin Epidermal Stem Cells
2.5K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.5K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K


